Mindfulness as effective as antidepressant

The Buddha taught mindfulness.

Mindfulness-based stress reduction (MBSR) was found to be as effective as the antidepressant escitalopram in reducing agoraphobia, panic disorder, generalized anxiety disorder, and social anxiety disorder symptoms.

The muti-institution study, led by the National Institute of Mental Health in Bethesda, Maryland, suggests that mindfulness (sati) practices may offer a viable alternative to medication for treating anxiety disorders, with significantly fewer side effects.

Anxiety disorders affect millions of people and are frequently treated with medications like selective serotonin reuptake inhibitors (SSRIs).

Ketamine and psychedelics may also work better than toxic antidepressants.

.
While SSRIs can be an effective tool in countering the symptoms of anxiety disorders, they also come with side effects that can negatively impact a patient's quality of life in other ways.

In the case of escitalopram (sold as Lexapro and Cipralex), these adverse effects include nausea, headaches, dry mouth, excessive sweating, insomnia, and fatigue.

The research team previously demonstrated that eight weeks of mindfulness-based stress reduction (MBSR) was non-inferior to escitalopram in providing stress relief and emotional regulation without having the additional drawbacks (avoiding the side effects of synthetic allopathic drugs).

In a new research letter, "Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders: Secondary Analysis of a Randomized Clinical Trial," published in JAMA Network Open, the team presents the secondary outcomes of patient-reported anxiety, depression, and quality of life from the previous study.

• Related video: Healing from Depression and Navigating Obsession (Francesca Tighinean) This is one of the darkest manipulation techniques that people...

The study

Drugs disrupt enzyme processes like magic.

The study involved 276 adults diagnosed with various anxiety disorders (including agoraphobia, panic disorder, generalized anxiety disorder, and social anxiety disorder). Participants were randomly assigned to either the MBSR program or escitalopram treatment. The MBSR group attended weekly sessions focused on mindfulness meditation techniques, while the escitalopram group received dosages ranging from 10 to 20 mg per day with regular clinical follow-ups. Researchers used multiple standardized scales to measure anxiety, depression, and quality of life, both from patient and clinician perspectives. Blinded evaluators conducted assessments using tools like the Beck Anxiety Inventory and the PROMIS Anxiety Short Form.

• How psilocybin the psychedelic in 'magic mushrooms' may rewire the brain to ease depression anxiety and more
• Science explains mind-altering effects of 'magic' mushrooms
• Neuroscientists reveal how magic mushrooms work on the brain
• Psychedelic found to reduce anxiety, research says
• Psychedelic drug DOI activates specific brain neurons to ease anxiety
• The truth about using psilocybin for depression
• Neuroscience research sheds light on how psilocybin alters spatial awareness
• IP protection of psychedelics
• The clinic for psychedelic difficulties: where people go when the trip never really ends
• Extra strong cannabis changes drug users’ DNA, study finds
• 12 metal musicians who surprisingly stayed drug free
• Magic mushroom strains: Is there really a difference?
• Breakthrough headset could be used to help treat depression at home
• Headphones which Zap the brain could help tackle depression
• Meditation works to relieve pain and is not placebo study shows
• Meditation can backfire worsening mental health problems
• Psychedelic drugs and treating mental illness
• People with depression may have key brain difference
• How to supercharge your dopamine levels naturally to help stop feeling depressed or anxious
• Study identifies brain regions that are almost twice as large in people living with depression
• Alert over huge rise in dangerous opioid painkillers use
• VIDEO: The future of mental health treatment: Psychedelic mushrooms on the rise
• After 20 years in the finance industry, I felt depressed and anxious — until I started microdosing. It helped me see how I was holding myself back

Findings

I'll take Nature over Big Pharma any day.

Findings revealed that both groups experienced similar reductions in anxiety symptoms over the study period. No significant differences were detected between MBSR and escitalopram in overall anxiety reduction by Week 8, the study's primary endpoint.

Escitalopram showed a slight edge in symptom reduction at the mid-treatment point (Week 4), but these improvements were not sustained by the end of the study.

Adverse event rates were the only significant difference between the two treatments. Nearly 79% of escitalopram recipients reported at least one study-related side effect, compared to just 15% of those in the mindfulness group.

The findings lend greater support for the use of mindfulness-based stress reduction as a reliable treatment for anxiety disorders with fewer risks, making a compelling case for its broader application in clinical settings. Source: Mindfulness found as effective as leading antidepressant in treating anxiety disorders

• More info: Hiroe Hu et al, "Mindfulness Meditation vs Escitalopram for Treatment of Anxiety Disorders," JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.38453 © 2024 Science X Network.
• This story was originally published in Medical Xpress. Subscribe to newsletter for the latest sci-tech news updates
• Medical Xpress via MSN.com, 10/24/24; Ananda (Dharma Buddhist Meditation), Ashley Wells (eds.), Wisdom Quarterly